Cooperatieve AESCAP Venture I U.A. 13D and 13G filings for F-star Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-26 4:31 pm Unchanged | 2021-05-12 | 13D | F-star Therapeutics, Inc. FSTX | Cooperatieve AESCAP Venture I U.A. | 615,643 3.100% | 0 (Unchanged) | Filing |
| 2020-12-03 5:08 pm Purchase | 2020-11-20 | 13D | F-star Therapeutics, Inc. FSTX | Cooperatieve AESCAP Venture I U.A. | 615,643 6.800% | 615,643 (New Position) | Filing |